Susan Abdel-Rahman, PharmD
Marion Merrell Dow/Missouri Chair
Pediatric Clinical Pharmacology
University of Missouri-Kansas City
Kansas City, MO, USA
Susan M. Abdel-Rahman, PharmD, is a Professor of Paediatrics at the UMKC-School of Medicine, Director of Health Care Innovation for the Children’s Research Institute, Chief of the Section of Therapeutic Innovation, and Program Director for the NIH T32 funded fellowship in Psediatric Clinical Pharmacology at Children’s Mercy. Dr Abdel-Rahman came to Children’s Mercy after completing undergraduate and graduate training at Rutgers University and a post-doctoral fellowship at the Ohio State University. Dr Rahman has been involved in translational and clinical research for nearly 20 years with grants/contracts from the National Institutes of Health, US Food and Drug Administration, World Health Organisation, Centres for Disease Control, National Endowment for the Arts, Pharmaceutical Industry and Private foundations. She directs a laboratory-based research program emphasising analytical chemistry/molecular genetics and has overseen more than two dozen clinical studies; from small, single-site pharmacokinetic studies to large population based epidemiologic investigations. Notably, Dr Rahman has enrolled over 28,000 participants into studies for which she served as the Principal Investigator. Dr Rahman leads a drug discovery program, is developing EHR-integrated precision therapeutics software, and has developed three medical devices two of which have been cleared by the FDA (2015 & 2019). Dr Rahman is also an active member of the Clinical Pharmacology consult service, taking call approximately 15 days per month. Dr Rahman chairs the Drug Utilisation Review Board for the state of Missouri’s Medicaid program and currently serves as President-Elect for the American Society of Clinical Pharmacology and Therapeutics (ASCPT). She will assume the role of ASCPT President at the Annual Meeting in 2020.